Skip to main content

Kraig Biocraft Laboratories, Inc.

corporate_fare Company Profile

Kraig Biocraft Laboratories, Inc.

KBLB·OTC·Industrial Applications And Services·CIK 0001413119

Kraig Biocraft Laboratories, Inc. is a Wyoming corporation focused on developing high-strength fibers using recombinant DNA technology for commercial applications, including technical textiles. The company uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Applications for this technology include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and more. Kraig Biocraft Laboratories believes it is the world's leading company in the research, development, and production of commercially scalable and cost-effective recombinant spider silk fiber. Its primary proprietary fiber technology utilizes natural and engineered variants of spider silk produced in domesticated mulberry silkworms. The company applies twenty-first-century biotechnology to the historical silk industry, introducing materials with innovative properties into an established commercial ecosystem of silkworm rearing, silk spinning, weaving, and manufacturing of garments and other products. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for target markets, including the specialty fiber and technical textile industries. The company believes its genetically engineered protein-based fibers have properties superior to materials currently available. Its technology has potential for ballistic-resistant materials and other applications requiring lightweight and high strength. The introduction of gene sequences based on native spider silk results in a self-perpetuating germline transformation. The recombinant spider silk fibers incorporate silk proteins found in spider silk with native silkworm silk proteins, creating new and unique recombinant silk fibers. This protein expression platform also has potential applications in diagnostics and pharmaceutical production.

Kraig Biocraft Laboratories, Inc. (OTC:KBLB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for KBLB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for KBLB spans 10-Q, 424B3, 8-K.

Recent high-impact activity:

  • Kraig Biocraft Q3 2026: Going Concern Reiterated, $3.1M Nine-Month Loss, Cash Up to $2.78M
  • Kraig Biocraft Fulfills First Commercial Order, Ramps All Three Production Centers
  • Kraig Biocraft Boosts Spider Silk Output 30% in Rainy Season, Eyes More Land
  • Kraig Biocraft Labs Achieves New Record: Delivers Nearly 2.5 Metric Tons of Recombinant Spider Silk
  • Immortalized Silk Gland Cell Breakthrough Promises Enhanced Spider Silk Production for Kraig Biocraft Labs

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$3.62M
Diluted EPS
$0.00
Op. Cash Flow
-$1.79M
Free Cash Flow
-$1.79M
Operating Income
-$3.37M
Cash & Equivalents
$1.79M
Debt / Equity
0.00×
Shares Outstanding
1.06B sh
Source: 10-K · filed 2026-03-30 · accession 0001493152-26-013630

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 20,105 shares in KBLB as of the October 30, 2026 settlement, a 92.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 25.9% of KBLB volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)20,105 shares as of October 30, 2026
Change vs prior period▼ 92.8%
Days to cover1.00 at avg daily volume of 1,112,659
Daily short volume (FINRA facilities)25.9% of 607,250 shares on November 20, 2026
5-day average short volume27.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with K →
$0.0766 -4.63% today
52-week range · as of 2026-11-16 $0.065 – $0.16
Market cap
$85.43M
Volume
607.3K (1.1× avg)
3-mo avg 571.3K
Live data · 2026-11-22 03:42 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed KBLB - Latest Insights

KBLB
Nov 16, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0795
Real-time Price: $0.0766 info
Change: -$0.0029 (-4%) info
Market Cap: $85.435M info
KBLB
Oct 05, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.1022
Real-time Price: $0.0766 info
Change: -$0.0256 (-25%) info
Market Cap: $85.435M info
KBLB
Aug 24, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0868
Real-time Price: $0.0766 info
Change: -$0.0102 (-12%) info
Market Cap: $85.435M info
KBLB
Jun 09, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.120395
Real-time Price: $0.0766 info
Change: -$0.043795 (-36%) info
Market Cap: $85.435M info
KBLB
May 20, 2026, 7:35 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.13185
Real-time Price: $0.0766 info
Change: -$0.05525 (-42%) info
Market Cap: $85.435M info
KBLB
May 14, 2026, 4:41 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.14105
Real-time Price: $0.0766 info
Change: -$0.06445 (-46%) info
Market Cap: $85.435M info
KBLB
May 14, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.14105
Real-time Price: $0.0766 info
Change: -$0.06445 (-46%) info
Market Cap: $85.435M info
KBLB
May 14, 2026, 8:14 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.1445
Real-time Price: $0.0766 info
Change: -$0.0679 (-47%) info
Market Cap: $85.435M info
KBLB
May 14, 2026, 8:09 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.1445
Real-time Price: $0.0766 info
Change: -$0.0679 (-47%) info
Market Cap: $85.435M info
KBLB
May 11, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.144
Real-time Price: $0.0766 info
Change: -$0.0674 (-47%) info
Market Cap: $85.435M info
KBLB
Apr 30, 2026, 5:07 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.14943
Real-time Price: $0.0766 info
Change: -$0.07283 (-49%) info
Market Cap: $85.435M info
KBLB
Apr 28, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.14764
Real-time Price: $0.0766 info
Change: -$0.07104 (-48%) info
Market Cap: $85.435M info
KBLB
Apr 20, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.14388
Real-time Price: $0.0766 info
Change: -$0.06728 (-47%) info
Market Cap: $85.435M info
KBLB
Apr 06, 2026, 7:17 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.11246
Real-time Price: $0.0766 info
Change: -$0.03586 (-32%) info
Market Cap: $85.435M info
KBLB
Mar 30, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.1192
Real-time Price: $0.0766 info
Change: -$0.0426 (-36%) info
Market Cap: $85.435M info
KBLB
Mar 23, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.115975
Real-time Price: $0.0766 info
Change: -$0.039375 (-34%) info
Market Cap: $85.435M info
KBLB
Mar 05, 2026, 7:05 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.11445
Real-time Price: $0.0766 info
Change: -$0.03785 (-33%) info
Market Cap: $85.435M info
KBLB
Feb 18, 2026, 11:17 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.090
Real-time Price: $0.0766 info
Change: -$0.0134 (-15%) info
Market Cap: $85.435M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets